Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Valvular AFib heightens risk in TAVR

Key clinical point: Valvular atrial fibrillation raises risk of poor outcomes in transcatheter aortic valve replacement.

Major finding: 24.2% of valvular AFib patients had poor outcomes vs. 14.5% of nonvalvular AFib patients.

Study details: Retrospective analysis of 1,472 patients at the Bern University Hospital who had TAVR for aortic stenosis between August 2007 and June 2018.

Disclosures: Dr. Okuno has no relevant financial relationships to report.

Citation:

Okuno T et al. JACC Cardiovasc Interv. 2020 Sep 21. doi: 10.1016/j.jcin.2020.05.049.